Case report:

72-year-old Caucasian female with mild-to-moderate atopic dermatitis. Clinical studies of EUCRISA did not include sufficient numbers of subjects age 65 and over to determine whether they respond differently from younger subjects.

All patients may not respond to treatment with EUCRISA. Individual results may vary.

Photos by Jason Smith, MD (Dermatologist - Rome, GA).

Back to top

References

  1. EUCRISA® (crisaborole) Full Prescribing Information. December 2018.